MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-22-2026
Quest Diagnostics Incorporated EBITDA per Share 2011-2026 | DGX
Annual EBITDA per Share Quest Diagnostics Incorporated
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 19.1 | 16.6 | 15.2 | 16.1 | 22.3 | 17.4 | 9.9 | 8.79 | 9.04 | 8.79 | 7.96 | 7.43 | 7.11 | 8.04 | 6.69 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 22.3 | 6.69 | 12 |
Quarterly EBITDA per Share Quest Diagnostics Incorporated
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.96 | 4.71 | 5.19 | 4.38 | 4.06 | 4.25 | 3.75 | 4.04 | 4.11 | 3.68 | - | 4.31 | 4.23 | 5.2 | - | 6.12 | 5.06 | 5.72 | - | 5.98 | 2.78 | 1.94 | - | 2.93 | 2.87 | 2.48 | - | 2.8 | 2.81 | 2.54 | - | 2.68 | 2.81 | 2.49 | - | 2.77 | 3.45 | 2.23 | - | 4.92 | 2.61 | 2.12 | - | 2.31 | 2.38 | 1.97 | - | 6 | 2.82 | 1.88 | - | 3.27 | 3.01 | 2.34 | - | 3.37 | 2.87 | 0.58 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 6.12 | 0.58 | 3.47 |
EBITDA per Share of other stocks in the Diagnostics research industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
ICON Public Limited Company
ICLR
|
10.5 | $ 118.45 | 4.04 % | $ 9.77 B |  Irlanda |
 |
Centogene N.V.
CNTG
|
-0.94 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
-0.61 | - | - | $ 1.31 B |  USA |
 |
Agilent Technologies
A
|
5.49 | $ 115.84 | 0.68 % | $ 35.2 B | USA |
 |
Celcuity
CELC
|
-3.68 | $ 133.97 | -0.22 % | $ 6.26 B | USA |
|
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
-36.9 | $ 7.3 | -19.87 % | $ 9.71 M | USA |
 |
Castle Biosciences
CSTL
|
-0.07 | $ 21.26 | 7.97 % | $ 616 M | USA |
 |
Aspira Women's Health
AWH
|
-0.23 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-1.46 | - | -61.36 % | $ 2.46 M | USA |
 |
Fulgent Genetics
FLGT
|
-2.18 | $ 17.9 | 1.3 % | $ 551 M | USA |
 |
Biocept
BIOC
|
-1.79 | - | -13.05 % | $ 7.29 M | USA |
 |
Guardant Health
GH
|
-3.17 | $ 127.51 | 6.39 % | $ 16 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
0.00122 | - | - | $ 562 M |  Britain |
 |
CareDx, Inc
CDNA
|
-0.3 | $ 22.16 | 2.88 % | $ 1.18 B | USA |
 |
Chembio Diagnostics
CEMI
|
-0.65 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-0.38 | - | - | $ 9.42 M |  Israel |
 |
Interpace Biosciences
IDXG
|
1.02 | $ 1.8 | - | $ 7.96 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-22.8 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
-3.01 | $ 150.17 | 3.41 % | $ 23.9 B | USA |
 |
Global Cord Blood Corporation
CO
|
5.37 | - | - | $ 399 M |  China |
 |
Lantheus Holdings
LNTH
|
5.64 | $ 99.09 | -0.97 % | $ 6.69 B | USA |
 |
Genetic Technologies Limited
GENE
|
-1.27 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-1.12 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-3.17 | - | -11.32 % | $ 2.94 M | USA |
 |
Mettler-Toledo International
MTD
|
2.48 | $ 1 093.84 | -0.68 % | $ 22.5 B |  Schweiz |
 |
Charles River Laboratories International
CRL
|
8.64 | $ 164.49 | 4.95 % | $ 8.15 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
8.68 | - | - | $ 10.7 B | USA |
 |
NeoGenomics
NEO
|
-0.62 | $ 9.57 | 3.24 % | $ 1.23 B | USA |
 |
Enzo Biochem
ENZ
|
-218 | - | -8.98 % | $ 14.8 K | USA |
 |
Medpace Holdings
MEDP
|
19.5 | $ 428.0 | -0.26 % | $ 12.3 B | USA |
 |
National Research Corporation
NRC
|
1.35 | $ 19.13 | 0.47 % | $ 428 M | USA |
 |
Natera
NTRA
|
-5.33 | $ 203.11 | 1.1 % | $ 20 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-0.43 | - | - | $ 19.8 B | USA |
 |
Myriad Genetics
MYGN
|
-3.6 | $ 3.94 | 2.34 % | $ 365 M | USA |
 |
Personalis
PSNL
|
-0.87 | $ 9.49 | 6.15 % | $ 847 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
2.69 | $ 26.6 | -1.26 % | $ 25.2 B |  Niderland |
 |
Senseonics Holdings
SENS
|
-1.6 | $ 6.32 | -1.71 % | $ 264 M | USA |
 |
QIAGEN N.V.
QGEN
|
3.04 | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
0.22 | - | - | $ 2.69 B | USA |
 |
Twist Bioscience Corporation
TWST
|
-1.86 | $ 64.17 | -1.08 % | $ 3.84 B | USA |
 |
Biomerica
BMRA
|
-2.2 | $ 2.46 | -0.61 % | $ 5.65 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
24.8 | $ 258.25 | -0.08 % | $ 21.5 B | USA |
 |
Thermo Fisher Scientific
TMO
|
23.3 | $ 456.21 | 1.79 % | $ 172 B | USA |
 |
Waters Corporation
WAT
|
6.02 | $ 342.18 | 1.05 % | $ 20.4 B | USA |
 |
Trinity Biotech plc
TRIB
|
-0.06 | $ 0.68 | 5.04 % | $ 244 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
-7.41 | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
-4.34 | $ 9.2 | 0.66 % | $ 2 B | USA |